partnering for the future Year Ended December 31, (US$ in millions, except share data) 2004 2003 2002 selected operating data, excluding one-time gain:  Volumes (in millions of metric tons) 109 106 86 Net sales $ 25,168 $ 22,165  $ 13,882 Total segment operating profi t$^{(a)}$ 850 618 521 Income from continuing operations before  income tax and minority interest 904 723 481 Net income $ 469 $  300 $ 255 Diluted earnings per share$^{(b)}$  $ 4.10 $  2.81 $  2.63 reconciliation to reported net income Net income before one-time gain $ 469 $  300 $ 255 Gain on sale of soy ingredients business – 111 – Net Income $ 469 $  411 $ 255 Diluted earnings per share before one-time gain $ 4.10 $  2.81 $  2.63 Gain on sale of soy ingredients business – 1.02 – Diluted earnings per share$^{(b)}$  $ 4.10 $ 3.83  $ 2.63 Diluted weighted average number of shares outstanding$^{(b)}$  115,674,056 108,654,027  97,395,005 fi nancial position  Working capital $ 2,766 $ 2,481  $ 1,655 Property, plant and equipment, net 2,536 2,090 2,056 Total assets 10,907 9,884 8,349 Long-term debt 2,600 2,377 1,904 Minority interest 280 554 495 Shareholders’ equity $ 3,375 $ 2,377 $  1,472 other information  Number of employees  24,621 23,295 24,207 (a) See page 36 for a reconciliation of total segment operating profi t to income from continuing operations before income tax and minority interest, which is the U.S.  GAAP fi nancial measure most directly comparable to total segment operating profi t.  (b) Includes 7,778,425 common shares issuable on conversion of Bunge’s 3.75% convertible notes due 2022. EPS for 2003 and 2002 were revised from the amount  previously reported to refl ect the 7,778,425 common shares issuable on conversion of the convertible notes. See notes 1 and 24 to the Notes to Consolidated  Financial Statements. (c) 2003 excludes an after tax gain on the sale of the Brazilian soy ingredients business of $111 million, or $1.02 per fully diluted share. (d) The calculation of return on shareholders’ equity excludes losses in 2003 of $7 million from discontinued operations and gains of $3 million in 2002 and 2001,  respectively, from discontinued operations and 2003 also excludes the $111 million gain on the sale of the Brazilian soy ingredients business. 1